期刊
NATURE MEDICINE
卷 23, 期 6, 页码 753-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.4328
关键词
-
资金
- Juvenile Diabetes Research Foundation
- Mary Iacocca Research Foundation
- NIH [1DP3DK112192-01, DK094333-01, 1R24DK090961-01]
- DRC grant [P30DK036836-30]
- JDRF [8-2005-358, 18-2008-363, CDA-2015-89-A-B]
- Thomas Beatson, Jr Foundation
- Brehm Foundation
- Sanofi-Aventis
- Harold Whitworth Pierce Charitable Trust Postdoctoral Fellowship
- [JDRF17-2011-47]
- [JDRF17-2013-310]
- [DK107339-02]
- [R01 DK109015]
- [R00 DK090210]
Diabetic nephropathy (DN) is a major cause of end-stage renal disease, and therapeutic options for preventing its progression are limited. To identify novel therapeutic strategies, we studied protective factors for DN using proteomics on glomeruli from individuals with extreme duration of diabetes (>= 50 years) without DN and those with histologic signs of DN. Enzymes in the glycolytic, sorbitol, methylglyoxal and mitochondrial pathways were elevated in individuals without DN. In particular, pyruvate kinase M2 (PKM2) expression and activity were upregulated. Mechanistically, we showed that hyperglycemia and diabetes decreased PKM2 tetramer formation and activity by sulfenylation in mouse glomeruli and cultured podocytes. Pkm-knockdown immortalized mouse podocytes had higher levels of toxic glucose metabolites, mitochondrial dysfunction and apoptosis. Podocyte-specific Pkm2-knockout (KO) mice with diabetes developed worse albuminuria and glomerular pathology. Conversely, we found that pharmacological activation of PKM2 by a small-molecule PKM2 activator, TEPP-46, reversed hyperglycemia-induced elevation in toxic glucose metabolites and mitochondrial dysfunction, partially by increasing glycolytic flux and PGC-1 alpha mRNA in cultured podocytes. In intervention studies using DBA2/J and Nos3 (eNos) KO mouse models of diabetes, TEPP-46 treatment reversed metabolic abnormalities, mitochondrial dysfunction and kidney pathology. Thus, PKM2 activation may protect against DN by increasing glucose metabolic flux, inhibiting the production of toxic glucose metabolites and inducing mitochondrial biogenesis to restore mitochondrial function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据